
Supplements and Featured Publications
- My Treatment Approach: Locally Advanced Lung Cancer
- Volume 1
- Issue 1
Dr. Costin on Initial Considerations in Early-Stage Lung Cancer
Dan Costin, MD, discusses initial considerations in early-stage lung cancer.
Dan Costin, MD, co-medical director, White Plains Hospital Center for Cancer Care, director, Cancer and Blood Specialists of New York, discusses initial considerations in early-stage lung cancer.
Patients with early-stage lung cancer typically require a multidisciplinary approach to treatment, says Costin. For example, thoracic surgeons, in addition to medical oncologists, will often be involved in initial treatment decisions.
In the early-stage setting, tissue diagnosis and appropriate staging are needed, says Costin. The majority of patients will undergo a CT-guided biopsy or a navigational bronchoscopy to determine tissue diagnosis. For staging, patients typically undergo a PET scan.
For a patient with a confirmed diagnosis of early-stage lung cancer, initial treatment selection is based on factors such as patient comorbidities, surgical eligibility, and results of molecular testing, concludes Costin.
Articles in this issue
almost 5 years ago
Recognizing the Value of Radiation Therapy in Lung Canceralmost 5 years ago
Dr. Sabari on the Role of Concurrent Molecular Testing in Lung Canceralmost 5 years ago
Sabari Stresses the Importance of Molecular Testing in Lung Cancerabout 5 years ago
Dr. Stiles on Treatment Advances Made in Early-Stage Lung Cancerabout 5 years ago
Dr. Rohs on the Role of Molecular Testing in Lung Cancer Managementabout 5 years ago
Navigating Nuances in Early and Metastatic Lung Cancer Treatmentabout 5 years ago
Capitalizing on Multimodality Therapy in NSCLC


































